Class Action Alleges AbbVie, Allergan, Forest Labs Blocked Generic Form of Bystolic Beta Blocker from Market
September 16, 2020 A class action alleges AbbVie, Allergan and Forest Labs conspired to suppress market competition for Bystolic, a blockbuster high blood pressure treatment drug.